R adioreceptor studies on brain membranes have shown that binding sites with properties of insulin receptors are present in gross subdivisions of the rat brain, such as the olfactory bulb, hypothalamus, and cerebral cortex, 12 but the precise microanatomic location of insulin binding sites in the brain has been largely unknown. Binding sites for insulin have been found by autoradiography in circumventricular organs, 3 cerebral microvessels, 4 and the external plexiform layer of the rat olfactory bulb. 56 We have approached the problem of localizing brain insulin binding sites by techniques of in vitro autoradiography, which enable localization of radioligand binding in small anatomic regions of brain slices.
R adioreceptor studies on brain membranes have shown that binding sites with properties of insulin receptors are present in gross subdivisions of the rat brain, such as the olfactory bulb, hypothalamus, and cerebral cortex, 12 but the precise microanatomic location of insulin binding sites in the brain has been largely unknown. Binding sites for insulin have been found by autoradiography in circumventricular organs, 3 cerebral microvessels, 4 and the external plexiform layer of the rat olfactory bulb. 56 We have approached the problem of localizing brain insulin binding sites by techniques of in vitro autoradiography, which enable localization of radioligand binding in small anatomic regions of brain slices. 7 Our autoradiographic films of brain slices labeled with 125 l-insulin consistently revealed high binding in the choroid plexuses. These results were unexpected because it has been claimed that the choroid plexus is devoid of insulin receptors. 38 A previous report briefly mentioned observing "somewhat elevated levels of insulin binding sites" in the choroid plexus, but no photographs, quantitative data, or information of specificity of insulin binding in the choroid plexus were presented. 5 In the present study, we measured the optical densities in small anatomic regions of the autoradiographic film images using a computer digital imaging system. With this method, we quantified the concentration of binding sites for 125 l-insulin in the choroid plexus and demonstrated specificity of binding for an insulin-like molecule.
MATERIALS AND METHODS
Male Long-Evans rats (250-300 g), anesthetized with pentobarbital, were perfused with 0.9% NaCI at 0°C via the left cardiac ventricle. The brain was removed and frozen in Freon 22 at -40°C. Binding assays were carried out on coronal slices (20 |xm) of the unfixed, frozen brains, which were sectioned with a cryostat and mounted on gelatin-coated slides. Trace insulin was human A-14 125 l-insulin 9 (specific activity 300 IxCi/jxg) diluted in 20 mM Hepes buffer, pH 8.0, containing BSA (0.5%), bacitracin (0.025%), N-ethylmaleimide (0.012%), and Aprotinin (100 KlU/ml). Each brain slice was covered with 0.2 ml of 0.05 nM 125 l-insulin, either alone or mixed with 1 |xM unlabeled porcine insulin, ribonuclease B, or glucagon, and incubated for 2 h at 23°C. The slides were then passed through three rinses in buffer at 0°C (2 min each) and rapidly dried on a hot plate at 60°C. Preliminary studies, in which labeled brain slices were wiped from the slides with filter paper and counted for radioactivity, showed that at 23°C, binding reached equilibrium by 90 min and did not change for 3 h, and that specific binding was 70-80% of total binding. Similarly prepared slide-mounted liver slices were also labeled and used for autoradiography.
The labeled and dried brain and liver slices were placed in direct contact with the emulsion of LKB Ultrofilm in an xray cassette and exposed for 5 days at 23°C; film was then developed in Kodak D-19 (4 min, 20°C). Quantitative analysis of 125 l-insulin binding was made with a microcomputer digital imaging system that accurately measures optical density in anatomic regions (of >150 ujn) of the autoradiographic image, and converts these to concentrations of labeled insulin (by reference to a standard curve relating optical density to concentration of radioactivity in the tissue slices). 10 This system has been extensively evaluated in our laboratory for quantitative autoradiography with 125 l-insulin. 11 Binding was expressed as fmol/mm 2 of the section area scanned rather than per unit weight of protein because the protein content of different regions measured was not known. Specific binding of 125 l-insulin was calculated by subtracting radioactivity bound in the presence of 1 |xM uniabeied insulin (nonspecific binding) from radioactivity bound with iodoinsulin alone (total binding). Statistical evaluations were done with the Student f-test.
RESULTS
Autoradiographic images of forebrain slices incubated with 0.05 nM 125 l-insulin alone showed an intense autoradiographic reaction in areas that coincided with the choroid plexus of the lateral and third ventricles (Figure 1 ). These labeled structures were unambiguously recognizable as choroid plexuses by their morphology and anatomic position. The photographic optical density of the choroid plexus images was visibly much darker than surrounding regions, and was reduced to background density (nonspecific binding) in the presence of 1 |xM uniabeied insulin. Likewise, the choroid plexus of the fourth ventricle was dark in images of hindbrain that were labeled with iodoinsulin used alone, and was very light when 1 |xM uniabeied insulin was added (Figure 2) . When 1 |xM ribonuclease or glucagon was mixed with the labeled insulin, the autoradiographic densities produced by the choroid plexuses were not visibly reduced. Although other brain regions, such as the cingulate cortex, showed optical densities above background, none approached the intense optical density produced by labeled choroid plexuses. These results have been reproduced in 28 rats.
Computer densitometry measurements showed high total and specific binding for 125 l-insulin in all choroid plexuses. Representative data from a single experiment are shown in Figure 3 . Specific binding (mean ± SEM of 4-8 measurements) was highest (P < 0.01) in the choroid plexus of the lateral ventricles (26.9 ± 2.0 x 10~3 fmol/mm 2 ) and the choroid plexus of the fourth ventricle (18.3 ± 3.0 x 10" 3 fmol/ mm 2 ). In the choroid plexus of the third ventricle, specific binding (13.2 ± 1.5 x 10~3 fmol/mm 2 ) was similar to the specific binding to liver slices (13.7 ± 0.6 x 10~3 fmol/mm 2 ) and the external plexiform layer of the olfactory bulb (15.2 ±0.2 x 10" 3 fmol/mm 2 ). Specific binding of 125 l-insulin to all choroid plexus regions was significantly higher than to the cingulate cortex (P < 0.001).
DISCUSSION
This study has shown that autoradiographic images of choroid plexuses were visibly darker than surrounding regions when labeled with 0.05 |xM background levels when 1 |xM unlabeled porcine insulin was included with trace insulin. Ribonuclease and glucagon did not have this effect. These results suggest that the choroid plexuses contain binding sites with specificity for an insulinlike molecule.
In related studies, we have found that insulin binding sites are concentrated in numerous anatomic regions throughout the brain. 6 However, concentrations of insulin binding sites in the choroid plexuses are higher than we have found in any other brain region. Computer densitometry verified that the Figure 1 and also because it is a region that shows insulin binding representative of numerous other brain regions. 6 concentration of specific binding sites for insulin in the choroid plexuses was equal to or greater than in the olfactory bulb external plexiform layer, a synaptic region rich in insulin binding sites. 56 Since insulin receptors are present in brain microvessels, 4 ' 12 it is possible that the high density of insulin binding sites in the choroid plexus is a reflection of the tight packing of capillaries in this richly vascular structure. The cellular location of insulin binding in the choroid plexus is not known, however. Insulin binding sites could also be present on cerebrospinal fluid (CSF) contacting surfaces and/or on basolateral membranes of choroid plexus epithelial cells.
A previous autoradiographic study found that labeled plasma insulin was taken up by the choroid plexus, but concluded that the binding was mostly nonspecific. 4 Our results, in contrast, clearly demonstrate the presence of insulin-specific binding sites in the choroid plexus. These seemingly conflicting results are undoubtedly due to the different methods used to identify insulin binding in the choroid plexus. Our studies were done under equilibrium binding conditions on a preparation in which labeled insulin had equal access to both sides of the blood-brain barrier and unbound insulin was rapidly separated from the bound ligand. The former results were based on rapid in vivo uptake of labeled plasma insulin on the blood side of the blood-brain barrier. It is possible that under in vivo conditions used in the earlier work, unbound insulin could have been "trapped" in the perivascular connective tissue spaces of the choroid plexus, and contributed to the high nonspecific binding levels reported. Our results clearly indicate that the choroid plexus contains numerous specific binding sites for insulin or an insulin-like molecule.
The function of insulin binding sites in the choroid plexus is not known. It is possible that the reported satiety-promoting effects of CSF insulin 13 may be mediated by the action of CSF insulin on the choroid plexus. It is also possible that the transport functions of the choroid plexus, and thus choroid plexus regulation of CSF composition, may be under the influence of insulin in plasma or CSF. Furthermore, the presence of specific binding for insulin in the choroid plexus raises the possibility that a site for the transport of insulin from blood to CSF may be located in the choroid plexus epithelium.
